Clinical Trials Directory

Trials / Completed

CompletedNCT00229034

Effect of APC and Epo on the Inflammatory Response During Sepsis

Effect of Activated Protein C and Erythropoietin on the Microvascular Inflammatory Response During Severe Sepsis.

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

An observational study to determine the effect of APC and Epo in reducing the systemic inflammatory response during severe sepsis.

Detailed description

An observational study to determine the effect of APC and Epo in reducing the systemic inflammatory response during severe sepsis. Patients already prescribed either drug will be enrolled. The microcirculation of the sublingual vascular bed will be observed with a microscope to detect the alterations in the inflammatory response.

Conditions

Timeline

Start date
2005-09-01
Primary completion
2010-12-01
Completion
2011-09-01
First posted
2005-09-29
Last updated
2017-08-25

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00229034. Inclusion in this directory is not an endorsement.